Vita means life. It's also our platform for sharing the stories of biotech's promise to patients and public health.
CSL consists of CSL Behring, CSL Seqirus and CSL Vifor. Learn more by visiting each section.
Biotechnology leader CSL Behring offers the broadest range of quality plasma-derived and recombinant therapies in our industry.
Derived from the expression 'securing health for all of us', CSL Seqirus is one of the world's largest influenza vaccine providers.
R&D focuses its expertise on four strategic platforms: plasma protein technology; recombinant technology; cell and gene therapy; and vaccines technology.
One of our core values at CSL is Innovation. We support collaborative innovation through the endowment of awards and grants to researchers around the world.
As part of our broader sustainability strategy to build a more sustainable future, CSL commits to reduce absolute Scope 1 and 2 greenhouse gas emissions by 42% by FY2030.
Along with our sustainability strategy, CSL’s community contribution framework helps deliver on our Values and support execution of our 2030 strategy.
At CSL, Inclusion and Belonging is at the core of our mission and who we are. It fuels our innovation day in and day out.
Whether you are early in your college education or recently completed your degree, it's never too soon to consider CSL for your Promising Future!
Anemia disrupts the lives of women around the world. The Global Alliance for Patient Access urges global policymakers to adop…
A first-of-its kind program created by Wake Tech Community College aims to meet the biopharmaceutical sector’s need for skill…
Hear six personal stories from CSL colleagues in Australia about how women’s health care has impacted their lives. Together, …
The facility, launched in 2018, is among 11 core facilities associated with the Huck Institutes of the Life Sciences at Penn …
The rare condition can be easily misdiagnosed. This short video explains common signs and symptoms of chronic inflammatory de…
We're supporting these organisations in making a positive difference to patients and communities across Australia.
Learn how to participate in the Living Rare Study, which aims to document the burden of rare diseases over time.
The Australian manufacturing site, which turns human plasma into critical medicines, was honored for its “full-scale” use of …
Did you know? Some scientists believe the Vikings may have passed down the inherited rare condition Alpha-1 Antitrypsin Defic…
Americas
Asia Pacific
Middle East
Europe
